US$ 25.33
glp 1 cardiovascular disease and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia GLP-1 and the cardiovascular system
Description
Other types of GLP-1 agonists include dulaglutide (Trulicity), liraglutide (Saxenda), and tirzepatide (Zepbound and Mounjaro), whose manufacturers are also facing lawsuits

27,36 In a controlled study, 63 patients with type 2 diabetes and a lower-extremity ulcer were randomized to either saxagliptin 5 mg or placebo daily

When severe symptoms dont respond to diet, medication may be an option

The claimant of the August 2023 lawsuit reported excessive, prolonged vomiting that caused her to lose some of her teeth
